Matches in Wikidata for { <http://www.wikidata.org/entity/Q64721699> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64721699 description "clinical trial" @default.
- Q64721699 description "ensayu clínicu" @default.
- Q64721699 description "klinisch onderzoek" @default.
- Q64721699 description "клінічне випробування" @default.
- Q64721699 name "Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU" @default.
- Q64721699 type Item @default.
- Q64721699 label "Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU" @default.
- Q64721699 prefLabel "Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU" @default.
- Q64721699 P1132 Q64721699-257ABC5D-0606-4AA6-B260-DFD12C8C610A @default.
- Q64721699 P1476 Q64721699-FDEA173B-7BFA-4EFF-8FC4-026939104ABB @default.
- Q64721699 P17 Q64721699-277E11F8-A07B-4EF4-885C-98A9AB3E23AB @default.
- Q64721699 P17 Q64721699-355BE5F2-8524-4588-A9A9-AEB3A205BA6D @default.
- Q64721699 P17 Q64721699-DED8C533-5D34-46AC-954E-17A728D87D66 @default.
- Q64721699 P17 Q64721699-FD0E8EF8-71D2-4D02-96DF-1F9CDDE6F98D @default.
- Q64721699 P1813 Q64721699-912C93BF-5F64-4E76-AF41-AD01C4444469 @default.
- Q64721699 P2899 Q64721699-A078CAF0-6024-42D0-8AF5-C66C1382EB3B @default.
- Q64721699 P3098 Q64721699-4509AF86-9275-4681-8B4D-B33794D064BF @default.
- Q64721699 P31 Q64721699-6A6DB41A-2FA0-4177-9213-8B8AE4BB4CA2 @default.
- Q64721699 P4844 Q64721699-55506394-EA09-4DBD-AFCA-11B0709F6E07 @default.
- Q64721699 P580 Q64721699-B30C466E-6BAE-401D-B797-A27534FA3F30 @default.
- Q64721699 P582 Q64721699-765F37F7-7789-4875-9D09-3EFC56B597E9 @default.
- Q64721699 P6099 Q64721699-41429A8C-7A14-4C85-8323-319201ECE0FA @default.
- Q64721699 P8363 Q64721699-993958E1-544F-4EE1-BD81-205BE26558A3 @default.
- Q64721699 P921 Q64721699-9602A74F-252D-450E-B080-82B1C8AE79A1 @default.
- Q64721699 P1132 "+613" @default.
- Q64721699 P1476 "A 12-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-national, Phase III, Efficacy and Safety Study of Inhaled Formoterol 4.5 μg and 9 μg Twice Daily in Japanese and European Patients With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64721699 P17 Q17 @default.
- Q64721699 P17 Q212 @default.
- Q64721699 P17 Q218 @default.
- Q64721699 P17 Q219 @default.
- Q64721699 P1813 "OCEAN" @default.
- Q64721699 P2899 "+40" @default.
- Q64721699 P3098 "NCT00628862" @default.
- Q64721699 P31 Q30612 @default.
- Q64721699 P4844 Q27132391 @default.
- Q64721699 P580 "2007-12-01T00:00:00Z" @default.
- Q64721699 P582 "2009-04-01T00:00:00Z" @default.
- Q64721699 P6099 Q42824827 @default.
- Q64721699 P8363 Q78089383 @default.
- Q64721699 P921 Q199804 @default.